131 results
A scary new facet of COVID-19 in children is starting to emerge. Here’s what we know about multisystem inflammatory syndrome in children (MIS-C).
In this unique EBM Focus article, the DynaMed team answers ten frequently asked questions about coronavirus disease 2019 (COVID-19).
Seven different COVID-19 vaccines are authorized around the world. Read about availability, vaccine types, vaccine efficacy, variants and vaccination precautions from the Infectious Disease team at DynaMed®.
High-quality randomized trials evaluating tocilizumab continue to show only modest effects in patients with severe COVID-19. Read about the latest trial in this EBM Focus article.
Read about new open access clinical care content in EBSCO’s COVID-19 Information Portal from Jessica Bartell, MD, MS, Chief Medical Officer, Clinical Decision Support, EBSCO Clinical Decisions.
Two categories of COVID-19-directed therapy are now available to high-risk outpatients with COVID-19: monoclonal antibody therapy and antiviral agents. Hear from DynaMed® editors about outpatient therapy.
COVID-19 is associated with coagulopathy and risk for thrombotic complications, but not all patients should get anticoagulation. Here is a new tool from the DynaMed Decisions® team at EBSCO that takes the guess work out of this clinical decision.
Ivermectin is an antiparasitic agent with in vitro activity against SARS-CoV-2 but as-of-yet unclear efficacy for treatment of COVID-19. The latest EBM Focus article discusses another trial.
Critical care physician Dr. Constantine Manthous shares his experience with respiratory management of critically ill patients with COVID-19 pneumonia.
Read an update from the DynaMed Infectious Disease team about five research discoveries that have impacted clinical care of patients with COVID-19 around the world.